Wilian Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,088
+461
+74% +$471K 0.77% 33
2026
Q1
$577K Sell
627
-28
-4% -$28.4K 1.42% 19
2025
Q4
$704K Buy
+655
New +$626K 0.76% 39

Other funds holding LLY

Wilian Securities's LLY Position: Q2 2026 in Review

Wilian Securities increased its Eli Lilly (LLY) stake by 74% in Q2 2026, buying an estimated $471K and bringing the position to 1,088 shares worth $1.31M. The position accounts for 0.77% of the portfolio, ranked #33.

Wilian Securities first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wilian Securities held 1,088 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • Wilian Securities bought 461 Eli Lilly shares in Q2 2026, an estimated $471K.
  • Eli Lilly made up 0.77% of Wilian Securities's portfolio in Q2 2026, its #33 holding.
  • Wilian Securities first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wilian Securities's 13F filing for Q2 2026, filed 13 Jul 2026.